日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma

RAS(ON)多选择性抑制剂联合疗法通过衰老相关的肿瘤免疫平衡触发胰腺导管腺癌的长期肿瘤控制

Caroline Broderick # ,Riccardo Mezzadra # ,Exequiel M Sisso ,Felix Mbuga ,Rashi Raghulan ,Almudena Chaves-Perez ,Amanda Kulick ,Lingyan Jiang ,Jingjing Jiang ,Yu-Jui Ho ,Janelle Simon ,Eric Rosiek ,Eric Chan ,Aveline Filliol ,Ronan Chaligne ,Elisa de Stanchina ,Ximo Pechuan-Jorge ,Andrea Schietinger ,Mallika Singh ,Scott W Lowe

RAS(ON) multi-selective inhibition drives antitumor immunity in preclinical models of NRAS-mutant melanoma

RAS(ON)多选择性抑制驱动NRAS突变型黑色素瘤临床前模型中的抗肿瘤免疫

Larissa Anastacio Da Costa Carvalho ,Nataliya Tovbis Shifrin ,Manali S Phadke ,Michael F Emmons ,Ximo Pechuan-Jorge ,Felix Mbuga ,Oscar E Ospina ,Christopher Chow ,Lillian Seu ,Olivia L Rose ,Aparna Hegde ,Nikhil I Khushalani ,Elsa Quintana ,Keiran S M Smalley